Ovidac 5000iu (HCG (Human Chorionic Gonadotropin))

Product Overview

Ovidac 5000iu is a sterile lyophilized injectable formulation that contains human chorionic gonadotropin (HCG) at a strength of 5000 international units per vial. The product is supplied by Bayer Zydus Pharma and is indicated for the management of female infertility and male hypogonadism. Each package includes one milliliter of reconstituted solution housed in a single vial, and the pack size can be 3, 6, or 9 vials depending on the prescribing regimen. The medication is shipped with a delivery window of six to fifteen days, allowing patients and clinicians to plan treatment cycles with certainty.

What is Ovidac 5000iu

Ovidac 5000iu belongs to the class of gonadotropins, hormones that stimulate the gonads. The active ingredient, HCG, is a glycoprotein derived from the urine of pregnant women and is identical in biological activity to the endogenous luteinizing hormone. In clinical practice the drug is used to trigger ovulation in women with ovulatory disorders and to enhance testosterone production in men with documented testicular insufficiency. The medication is presented as a powder that must be reconstituted with a supplied diluent before administration.

Uses and Benefits

Clinicians prescribe Ovidac 5000iu primarily to address ovulatory dysfunction in women who are attempting to conceive. By mimicking the natural surge of LH, the drug prompts the final maturation of ovarian follicles and facilitates the release of a mature oocyte. In the male population the same formulation can be employed to stimulate Leydig cell activity, thereby increasing endogenous testosterone levels in individuals diagnosed with primary or secondary hypogonadism. The therapeutic benefits include improved chances of pregnancy, restoration of hormonal balance, and potential enhancement of sperm parameters when used according to a physician’s protocol. Because the product is supplied in a controlled pack size, treatment courses can be tailored to individual needs while maintaining a consistent supply of medication.

How It Works

Human chorionic gonadotropin shares a common receptor with luteinizing hormone and therefore can bind to and activate the LH/hCG receptor on ovarian granulosa cells and Leydig cells. In the ovary this activation leads to increased production of cyclic AMP and subsequent resumption of meiosis, culminating in ovulation. In the testis, HCG stimulates the Leydig cells to produce testosterone, which in turn supports spermatogenesis. The pharmacodynamic profile of Ovidac 5000iu is characterized by a relatively long half‑life, allowing for less frequent dosing when administered under medical supervision. The drug’s effect is dose‑dependent, and the clinical response is monitored through laboratory assays such as serum estradiol, progesterone, or testosterone levels, as well as ultrasound imaging when appropriate.

Dosage Guidelines

Dosage of Ovidac 5000iu must always be individualized by a qualified healthcare professional. Typical regimens for ovulation induction in women involve a single intramuscular injection of the reconstituted dose at the time of expected follicular maturity, as determined by ultrasound or hormonal monitoring. In men, the standard approach may involve a series of weekly intramuscular injections over several weeks, with the exact schedule dictated by baseline hormone levels and the physician’s assessment. It is essential that patients do not self‑administer the medication without proper training and that all injections are performed using aseptic technique. The reconstitution process should follow the instructions provided with the product, and any unused portions should be discarded to prevent contamination. Because dosing is based on clinical judgment, patients should adhere strictly to the prescribing information and report any missed or extra doses to their provider.

Side Effects

Like all biologic agents, Ovidac 5000iu can be associated with adverse reactions. The most frequently reported side effects include mild injection site irritation, headache, and nausea. Some individuals may experience bloating, abdominal discomfort, or transient weight gain due to fluid retention. Less common but clinically significant events can involve Ovarian Hyperstimulation Syndrome (OHSS) in women, which manifests as severe pelvic pain, shortness of breath, and rapid weight increase, and may require medical intervention. In men, rare occurrences of gynecomastia or allergic reactions have been documented. Patients should be instructed to seek immediate medical attention if they develop symptoms such as intense abdominal pain, swelling of the face or tongue, or signs of a severe allergic reaction.

Warnings and Precautions

Ovidac 5000iu is contraindicated in patients who have a known hypersensitivity to HCG or any of the excipients in the formulation. The product should not be used in pregnant women unless the potential benefit justifies the potential risk, and it must be avoided in cases of known or suspected ovarian cysts, thyroid disease, or hormone‑sensitive tumors. Prior to initiation, a thorough medical history should be obtained, and baseline laboratory tests should be performed to assess renal and hepatic function. Concomitant use of other gonadotropins or hormonal therapies requires careful monitoring to avoid supraphysiologic hormone levels. Healthcare providers should also counsel patients on the potential for multiple pregnancy in women and on the importance of maintaining adequate nutrition and hydration throughout treatment.

Frequently Asked Questions

What condition does Ovidac 5000iu treat?

Ovidac 5000iu is indicated for female infertility related to ovulatory disorders and for male hypogonadism characterized by low testosterone levels.

How is Ovidac 5000iu administered?

The medication is supplied as a powder that must be reconstituted with the provided diluent and then administered by intramuscular injection under medical supervision.

Can Ovidac 5000iu be used for weight loss?

No, HCG products are not approved for weight loss or appetite suppression, and such use is not supported by clinical evidence.

Is a prescription required for Ovidac 5000iu?

Yes, Ovidac 5000iu is a prescription‑only medication and should only be used after evaluation by a qualified healthcare professional.

Where can I find more information about HCG therapy?

Authoritative details are available from sources such as the FDA, the NIH, and the MedlinePlus consumer health portal.

Related Products

• Clotrimazole Vaginal Cream 30 g (Generic)
• Canesten Vaginal Cream 30 g (Clotrimazole)
• Dexchlorpheniramine 2mg (Generic)
• Loratadine 10 Mg (Generic)
• Alaspan 10 mg (Loratadine)
• Alaspan AM (Ambroxol/Loratadine)
• Alaspan (Ambroxol/Loratadine)
• Polaramine 2 mg (Dexchlorpheniramine)
• Xarelto 20 mg (Rivaroxaban)
• Nublexa 40 mg (Regorafenib)
• Resihance Tablet (Regorafenib)
• Xarelto Tablet (Rivaroxaban)